Stockscreener 앱 받기
1.715
3.37%
-0.065
전일 마감가:
$1.78
열려 있는:
$1.76
하루 거래량:
1.87M
Relative Volume:
0.57
시가총액:
$383.44M
수익:
-
순이익/손실:
$-283.26M
주가수익비율:
-1.1667
EPS:
-1.47
순현금흐름:
$-273.61M
1주 성능:
-4.97%
1개월 성능:
+1.18%
6개월 성능:
-28.93%
1년 성능:
-81.45%
1일 변동 폭
$1.60
$1.78
1주일 범위
$1.60
$2.19
52주 변동 폭
$1.26
$9.49
사나 바이오테크놀로지 Stock (SANA) Company Profile
명칭
Sana Biotechnology Inc
전화
(206) 701-7914
주소
188 EAST BLAINE STREET, SUITE 400, SEATTLE
SANA을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
SANA
Sana Biotechnology Inc
|
1.72 | 383.44M | 0 | -283.26M | -273.61M | -1.47 |
|
VRTX
Vertex Pharmaceuticals Inc
|
433.02 | 111.66B | 11.10B | -988.90M | -1.26B | -3.92 |
|
REGN
Regeneron Pharmaceuticals Inc
|
580.55 | 60.56B | 14.09B | 4.50B | 2.96B | 39.28 |
|
ARGX
Argen X Se Adr
|
557.61 | 38.04B | 2.58B | 1.06B | -1.28B | 16.33 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
283.60 | 36.06B | 2.35B | -269.70M | -75.39M | -2.09 |
|
ONC
Beigene Ltd Adr
|
225.19 | 25.10B | 3.81B | -644.79M | -669.77M | -6.24 |
사나 바이오테크놀로지 Stock (SANA) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2025-03-18 | 업그레이드 | Citizens JMP | Mkt Perform → Mkt Outperform |
| 2025-03-14 | 개시 | Jefferies | Buy |
| 2025-01-08 | 업그레이드 | TD Cowen | Hold → Buy |
| 2024-11-05 | 다운그레이드 | JMP Securities | Mkt Outperform → Mkt Perform |
| 2024-06-26 | 개시 | Rodman & Renshaw | Buy |
| 2024-01-16 | 업그레이드 | H.C. Wainwright | Neutral → Buy |
| 2023-09-25 | 개시 | JMP Securities | Mkt Outperform |
| 2023-09-05 | 개시 | Citigroup | Buy |
| 2023-08-14 | 개시 | TD Cowen | Market Perform |
| 2023-05-02 | 개시 | H.C. Wainwright | Neutral |
| 2021-03-01 | 개시 | BofA Securities | Buy |
| 2021-03-01 | 개시 | Goldman | Neutral |
| 2021-03-01 | 개시 | JP Morgan | Neutral |
| 2021-03-01 | 개시 | Morgan Stanley | Overweight |
모두보기
사나 바이오테크놀로지 주식(SANA)의 최신 뉴스
Sana Biotechnology, Inc. (SANA) Class Action Lawsuit: Levi & Korsinsky Reminds Investors of May 20, 2025 Deadline - Stockhouse
Investors in Sana Biotechnology, Inc. Should Contact The Gross Law Firm Before May 20, 2025 to Discuss Your RightsSANA - WV News
Dimensional Fund Advisors LP Buys 478,596 Shares of Sana Biotechnology, Inc. (NASDAQ:SANA) - Defense World
Lost Money on Sana Biotechnology, Inc. (SANA)? Join Class Action Before May 20, 2025Contact Levi & Korsinsky - Stockhouse
INVESTOR DEADLINE APPROACHING: Faruqi & Faruqi, LLP - GlobeNewswire
INVESTOR DEADLINE APPROACHING: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Sana Biotechnology - Morningstar
INVESTOR DEADLINE APPROACHING: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Sana Biotechnology - GlobeNewswire Inc.
SANA Lawsuit Alert! Class Action Lawsuit Against Sana Biotechnology, Inc. - TipRanks
Sana Biotechnology, Inc. (NASDAQ: SANA) Investor Alert: Deadline in Lawsuit on May 20, 2025 - openPR.com
What Is The Outlook For Sana Biotechnology Inc (NASDAQ: SANA) Like For Short-Term? - Stocksregister
Class Action Filed Against Sana Biotechnology, Inc. (SANA) Seeking Recovery for InvestorsContact Levi & Korsinsky - PR Newswire
Hsbc Holdings PLC Increases Stake in Sana Biotechnology, Inc. (NASDAQ:SANA) - Defense World
Sana Biotechnology Reports Improved Quarterly Loss - TipRanks
Sana Biotechnology to Present at the BofA Securities 2025 Healthcare Conference - Stock Titan
INVESTOR ALERT: Pomerantz Law Firm Announces the Filing of a Class Action Against Sana Biotechnology, Inc. and Certain OfficersSANA - PR Newswire
Sana Biotechnology, Inc. Class Action: The Gross Law Firm Reminds Sana Biotechnology, Inc. ... - Eagle-Tribune
SANA Investors Have Opportunity to Lead Sana Biotechnology, Inc. Securities Fraud Lawsuit with the Schall Law Firm - PR Newswire
Wells Fargo & Company MN Has $101,000 Stake in Sana Biotechnology, Inc. (NASDAQ:SANA) - Defense World
Faruqi & Faruqi Reminds Sana Biotechnology Investors of the - GlobeNewswire
Faruqi & Faruqi Reminds Sana Biotechnology Investors of the Pending Class Action Lawsuit ... - Bluefield Daily Telegraph
Faruqi & Faruqi Reminds Sana Biotechnology Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of May 20, 2025 - GlobeNewswire Inc.
Shareholders of Sana Biotechnology, Inc. Should Contact Levi & Korsinsky Before May 20, 2025 to Discuss Your RightsSANA - ACCESS Newswire
2025-05-10 | Shareholders of Sana Biotechnology, Inc. Should Contact Levi & Korsinsky Before May 20, 2025 to Discuss Your RightsSANA | NDAQ:SANA | Press Release - Stockhouse
SANA INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC - GlobeNewswire
Levi & Korsinsky Notifies Shareholders of Sana Biotechnology, Inc.(SANA) of a Class Action Lawsuit and an Upcoming Deadline - Morningstar
Sana: Q1 Earnings Snapshot - New Haven Register
Sana Biotechnology Reports First Quarter 2025 Financial Results and Business Updates - GlobeNewswire
Shareholders that lost money on Sana Biotechnology, Inc.(SANA) should contact Levi & Korsinsky about pending Class ActionSANA - ACCESS Newswire
Optimistic Buy Rating for Sana Biotechnology Amid Promising Clinical Developments and Stable Financial Outlook - TipRanks
2025-05-08 | Levi & Korsinsky Reminds Sana Biotechnology, Inc. Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of May 20, 2025SANA | NDAQ:SANA | Press Release - Stockhouse
Sana Biotechnology Enters New $119M Sales Agreement - TipRanks
SANA LAWSUIT ALERT: Levi & Korsinsky Notifies Sana Biotechnology, Inc. Investors of a Class ... - Bluefield Daily Telegraph
The Gross Law Firm Reminds Shareholders of a Lead Plaintiff Deadline of May 20, 2025 in Sana Biotechnology, Inc. LawsuitSANA - Finansavisen
SANA Investors Have Opportunity to Lead Sana Biotechnology, Inc. Securities Fraud Lawsuit - GuruFocus
Lost Money on Sana Biotechnology, Inc. (SANA)? Join Class Action Suit Seeking RecoveryContact Levi & Korsinsky - ACCESS Newswire
Sana Biotechnology, Inc. Sued for Securities Law Violations – Investors Should Contact The ... - Bluefield Daily Telegraph
Sana Biotechnology, Inc. Sued for Securities Law Violations – Investors Should Contact The Gross Law Firm for More Information – SANA - TradingView
INVESTOR ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Sana Biotechnology - PR Newswire
Sana Biotechnology, Inc. Sued for Securities Law ViolationsContact Levi & Korsinsky Before May 20, 2025 to Discuss Your RightsSANA - ACCESS Newswire
Sana Biotechnology, Inc. (NASDAQ:SANA) Shares Sold by Marshall Wace LLP - Defense World
Shareholders that lost money on Sana Biotechnology, Inc. (SANA) Urged to Join Class ActionContact Levi & Korsinsky to Learn More - ACCESS Newswire
Levi & Korsinsky Reminds Shareholders of a Lead Plaintiff Deadline of May 20, 2025 in Sana ... - Bluefield Daily Telegraph
SHAREHOLDER REMINDER: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Sana Biotechnology - StreetInsider
Shareholders that lost money on Sana Biotechnology, Inc.(SANA) Urged to Join Class ActionContact The Gross Law Firm to Learn More - Finansavisen
Lost Money on Sana Biotechnology, Inc.(SANA)? Join Class Action Suit Seeking RecoveryContact Levi & Korsinsky - ACCESS Newswire
Sana Biotechnology, Inc. (NASDAQ:SANA) Shares Purchased by Renaissance Technologies LLC - Defense World
Comparing Sana Biotechnology (NASDAQ:SANA) & Aptose Biosciences (NASDAQ:APTO) - Defense World
Sana Biotechnology Inc expected to post a loss of 23 cents a shareEarnings Preview - TradingView
Sana Biotechnology, Inc. Class Action: Levi & Korsinsky Reminds Sana Biotechnology, Inc. Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of May 20, 2025SANA - PR Newswire
Shareholders that lost money on Sana Biotechnology, Inc. - GlobeNewswire
DEADLINE ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Sana Biotechnology - The Malaysian Reserve
사나 바이오테크놀로지 (SANA) 재무 분석
매출
순이익
현금흐름
주당 순 이익
사나 바이오테크놀로지 주식 (SANA) 내부자 거래
| 내부자 거래 | 관계 | 날짜 | 거래 | 비용 | #주식 | 가치 ($) | #주식 총계 |
|---|---|---|---|---|---|---|---|
| Cassidy Bernard J | EVP & General Counsel |
Mar 07 '25 |
Option Exercise |
0.00 |
11,041 |
0 |
115,823 |
| Harr Steve | President & CEO |
Mar 07 '25 |
Option Exercise |
0.00 |
50,000 |
0 |
7,889,750 |
| Wyrick Susan D. | See Remarks |
Mar 02 '25 |
Option Exercise |
0.00 |
1,525 |
0 |
155,471 |
1.74%
자본화:
|
볼륨(24시간):